Cycloamphilectenes, a new type of potent marine diterpenes: Inhibition of nitric oxide production in murine macrophages

Life Sciences

Volumn 72, Issue 22, 2003, Pages 2543-2552

  Lucas, Rut ^a   Casapullo, Agostino ^b   Ciasullo, Linda ^b   Gomez Paloma, Luigi ^b   Payá, Miguel ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

Cycloamphilectenes; INOS; Macrophages; NF kB; Nitric oxide; Zymosan

Indexed keywords

CYCLOAMPHILECTENE 1; CYCLOAMPHILECTENE 2; CYCLOAMPHILECTENE 3; CYCLOAMPHILECTENE 4; CYCLOAMPHILECTENE 5; CYCLOAMPHILECTENE 6; CYCLOOXYGENASE 2; DITERPENE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AXINELLA; CELL; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG ISOLATION; DRUG POTENCY; FEMALE; HUMAN; IC 50; INHIBITION KINETICS; NONHUMAN; PERITONEUM MACROPHAGE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SPONGE (PORIFERA); SYNTHESIS; WESTERN BLOTTING;

AXINELLA; MURINAE;

EID: 0345700742     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00167-X     Document Type: Article

References (29)

1. Alving K., Weitzberg E., Lundberg J.M. Increased amount of nitric oxide in exhaled air of asthmatics. European Respiratory Journal. 6(9):1993;1368-1370.
2. Bustos G., Ferrándiz M.L., Sanz M.J., Payá M., Alcaraz M.J. A study of the novel anti-inflammatory agent florifenine. Topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions. Naunyn-Schmiedeberg's Archives of Pharmacology. 351(3):1995;298-304.
3. Carlson R.P., O'Neill-Davis L., Chang J., Lewis A.J. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents and Actions. 17(2):1985;197-204.
4. Ciasullo L., Cutignano A., Casapullo A., Puliti R., Mattia C.A., Debitus C., Riccio R., Gomez-Paloma L. A new cycloamphilectene metabolite from theVanuatu sponge Axinella sp. Journal of Natural Products. 65(8):2002;1210-1212.
5. Ciavatta M.L., Fontana A., Puliti R., Scognamiglio G., Cimino G. Structures and absolute stereochemistry of isocyanide and isothiocyanate amphilectenes from the Caribbean sponge Cribochalina sp. Tetrahedron. 55(43):1999;12629-12636.
6. Cobb J.P., Danner R.L. Nitric oxide and septic shock. The Journal of the American Medical Association. 275(15):1996;1192-1196.
7. Deng G.M., Verdrengh M., Liu Z.Q., Tarkowski A. The major role of macrophages and their product tumor necrosis factor alpha in the induction of arthritis triggered by bacterial DNA containing CpG motifs. Arthritis and Rheumatism. 43(10):2000;2283-2289.
8. Di Rosa M., Radomski M., Carnuccio R., Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochemical and Biophysical Research Communications. 172(3):1990;1246-1252.
9. 2 with anti-inflammatory activity. Journal of Pharmacology and Experimental Therapeutics. 282(1):1997;123-131.
10. Goppelt-Struebe M. Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids. Biochemical Pharmacology. 53(10):1997;1389-1395.
11. Gross S.S., Levi R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. Journal of Biological Chemistry. 267(36):1992;25722-25729.
12. Iuvone T., Carnuccio R., Di Rosa M. Modulation of granuloma formation by endogenous nitric oxide. European Jounal of Pharmacology. 265(1-2):1994;89-92.
13. Jang D., Murrell G.A. Nitric oxide in arthritis. Free Radical Biology and Medicine. 24(9):1998;1511-1519.
14. Kang R.Y., Freire Moar J., Sigal E., Chu C.Q. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. British Journal of Rheumatology. 35(8):1996;711-718.
15. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Letters. 350(1):1994;9-12.
16. Lopez-Collazo E., Hortelano S., Rojas A., Bosca L. Triggering of peritoneal macrophages with IFN-alpha/beta attenuates the expression of inducible nitric oxide synthase through a decrease in NF-kappaB activation. Journal of Immunology. 160(6):1998;2889-2895.
17. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annual Review of Immunology. 15:1997;323-350.
18. Marcinkiewicz J., Grabowska A., Chain B. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. European Journal of Immunology. 25(4):1995;947-951.
19. Misko T.P., Schilling R.J., Salvemini D., Moore W.M., Currie M.G. A fluorometric assay for the measurement of nitrite in biological samples. Analytical Biochemistry. 214(1):1993;11-16.
20. Moroney M.A., Alcaraz M.J., Forder R.A., Carey F., Hoult J.R.S. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. Journal of Pharmacy and Pharmacology. 40(11):1988;787-792.
21. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 18(49):1999;6853-6866.
22. Palombella V.J., Conner E.M., Fuseler J.W., Destree A., Davis J.M., Laroux F.S., Wolf R.E., Huang J., Brand S., Elliott P.J., Lazarus D., McCormack T., Parent L., Stein R., Adams J., Grisham M.B. Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. Proceedings of the National Academy of Sciences of the United States of America. 95(26):1998;15671-15676.
23. Pennanen N., Lapinjoki S., Palander A., Urtti A., Monkkonen J. Macrophage-like RAW 264 cell line and time-resolved fluoroimmunoassay (TRFIA) as tools in screening drug effects on cytokine secretion. International Journal of Immunopharmacology. 17(6):1995;475-480.
24. Posadas I., Terencio M.C., Guillén I., Ferrándiz M.L., Coloma J., Payá M., Alcaraz M.J. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation. Naunyn-Schmiedeberg's Archives of Pharmacology. 361(1):2000;98-106.
25. Salvemini D., Manning P.T., Zweifel B.S., Seibert K., Connor J., Currie M.G., Needleman P., Masferrer J.L. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. Journal of Clinical Investigation. 96(1):1995;301-308.
26. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proceedings of the National Academy of Sciences of the United States of America. 90(15):1993;7240-7244.
27. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proceedings of the National Academy of Sciences of the United States of America. 91(25):1994;12013-12017.
28. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. Journal of Clinical Investigation. 107(1):2001;7-11.
29. Vane J.R., Mitchell J.A., Appleton I., Tomlison A., Bishop-Bailey D., Croxtall J., Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proceedings of the National Academy of Sciences of the United States of America. 91(6):1994;2046-2050.